Subsequent Events	9 Months Ended
Sep. 30, 2024
Subsequent Events
Subsequent Events	Note 10 – Subsequent Events On October 15, 2024, a lease for our new laboratory space located in North Carolina commenced upon substantial completion of all tenant improvements by the landlord. The term of the lease began September 1, 2024 and ends in sixty-one months or October 1, 2029 with one five-year extension period. Monthly rental payments required under the lease are subject to annual increases and range from $14,235 - $16,503 over the initial term of the lease. This lease will be accounted for under ASC Topic 842, Leases and will result in an operating lease ROU asset and liability on our consolidated balance sheet based on the net present value of lease payments required over the lease term. The one five-year extension period will not be included in the ROU asset and liability as it was not reasonably certain this option would be exercised at lease commencement. On November 4, 2024, our former Chief Executive Officer and Chairman of the Board filed a complaint against the Company alleging unpaid wages and a bonus. Management, in consultation with its attorneys, cannot reasonably estimate a loss associated with this complaint, at this time, as the matter is early in the process. If we are unsuccessful in defending this matter, we do not believe it would have a material impact to our financial position or results of operations. On November 11, 2024, the Company’s board of directors approved a registered offering for the sale of units consisting of common stock and the issuance of warrants. The transaction is expected to close before year-end 2024, subject to customary closing conditions for a transaction of this type.

Subsequent Events

9 Months Ended

Sep. 30, 2024

Note 10 – Subsequent Events

On October 15, 2024, a lease for our new laboratory space located in North Carolina commenced upon substantial completion of all tenant improvements by the landlord. The term of the lease began September 1, 2024 and ends in sixty-one months or October 1, 2029 with one five-year extension period. Monthly rental payments required under the lease are subject to annual increases and range from $14,235 - $16,503 over the initial term of the lease.

This lease will be accounted for under ASC Topic 842, Leases and will result in an operating lease ROU asset and liability on our consolidated balance sheet based on the net present value of lease payments required over the lease term. The one five-year extension period will not be included in the ROU asset and liability as it was not reasonably certain this option would be exercised at lease commencement.

On November 4, 2024, our former Chief Executive Officer and Chairman of the Board filed a complaint against the Company alleging unpaid wages and a bonus. Management, in consultation with its attorneys, cannot reasonably estimate a loss associated with this complaint, at this time, as the matter is early in the process. If we are unsuccessful in defending this matter, we do not believe it would have a material impact to our financial position or results of operations.

On November 11, 2024, the Company’s board of directors approved a registered offering for the sale of units consisting of common stock and the issuance of warrants. The transaction is expected to close before year-end 2024, subject to customary closing conditions for a transaction of this type.